Detalhe da pesquisa
1.
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
Lancet Oncol
; 18(2): 202-211, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993569
2.
Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 89(1): 62-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24030918
3.
Collaborative biomedicine in the age of big data: the case of cancer.
J Med Internet Res
; 16(4): e101, 2014 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24711045
4.
Monitoring a nuclear factor-κB signature of drug resistance in multiple myeloma.
Mol Cell Proteomics
; 10(11): M110.005520, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21846842
5.
The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors.
Cancers (Basel)
; 15(20)2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37894280
6.
Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a.
Blood
; 116(24): 5228-36, 2010 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-20841506
7.
microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
Blood
; 115(13): 2630-9, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20086245
8.
A novel TNF receptor-associated factor 6 binding domain mediates NF-kappa B signaling by the common cytokine receptor beta subunit.
J Immunol
; 185(3): 1606-15, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20622119
9.
An ET-CURE pilot project supporting undergraduate training in cancer research, emerging technology, and health disparities.
J Cancer Educ
; 27(3): 418-27, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22528637
10.
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC.
J Thorac Oncol
; 16(3): 428-438, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301984
11.
Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma.
JCI Insight
; 6(24)2021 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793338
12.
Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1alpha in hypoxia.
J Biol Chem
; 284(25): 16752-16758, 2009 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-19406746
13.
Proteomic contributions to personalized cancer care.
Mol Cell Proteomics
; 7(10): 1780-94, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18664563
14.
Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma.
Cancer Res
; 80(23): 5344-5354, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33023948
15.
Recommendations for patient similarity classes: results of the AMIA 2019 workshop on defining patient similarity.
J Am Med Inform Assoc
; 27(11): 1808-1812, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32885823
16.
Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease.
Leukemia
; 34(7): 1866-1874, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32060406
17.
The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance.
Clin Cancer Res
; 14(9): 2519-26, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18451212
18.
Optimizing Cancer Treatment Using Game Theory: A Review.
JAMA Oncol
; 5(1): 96-103, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30098166
19.
BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.
Cancer Cell
; 35(5): 752-766.e9, 2019 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085176
20.
HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma.
Br J Haematol
; 142(4): 551-61, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18503584